Live Breaking News & Updates on Robin Knifsend

Stay updated with breaking news from Robin knifsend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

From Politics To Industry Reputation Top Of Mind Topics For Execs In Biopharma

From trade relations to industry reputations, five biopharmaceutical executives share their thoughts on top-of-mind topics as we ready for 2022 and. ....

Ivan Dimov , Xalud Therapeuticsdiem Nguyen , Peter Mariani , Synthekinerobin Knifsend , Rob Wright , Bioivan Dimov , Diem Nguyen , Axogenpeter Mariani , Robin Knifsend , Eyepoint Pharmaceuticals , Us Political Affairs , Chief Editor , Life Science , Orca Bioivan Dimov , Orca Bio , Life Science Leader , Life Science Leadersubscriber , Eyepoint Pharmaceuticalsnancy Lurker , Xalud Therapeutics ,

What's The Biopharma Financial View For 2022

Here’s what 10 biopharmaceutical finance experts have to say as they prepare for 2022 and beyond. ....

New York , United States , Olivia Tyrrell , Peter Mariani , Parag Shah , Samir Gharib , Rob Wright , Troy Ignelzi , Robin Knifsend , Ivor Macleod , Baker Mckenzie , Health Ventures , Chief Editor , Life Science , Spruce Biosciences , Big Data , Karuna Therapeutics , Decibel Therapeutics , Any Biopharma , New Administration , Strategic Asset , Flagship Pioneering , Record Number Of Biopharma ,

BioSpace Movers & Shakers, June 4

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers. ....

Wills Eye Hospital , United States , M Karen Newell Rogers , Myers Squibb , Denise Strauss , Marc Semigran , Davidc Hanley , Eric Castaldi , Jen Hong , Meagher Flom , Marc Massiot , Newell Rogers , Robin Knifsend , Theodore Reiss , Jeff Cruikshank , Evelo Biosciences , Judith Robertson , Alexander Ferdon , Mike Nohaile , Nuvation Bio , Adam Drapczuk , Mark Plinio , Julia Haller , Antoni Ribas , Anne Walker , Ann Lee ,

Stanford spinout Synthekine raises $107.5M on promise of new way to attack cancer, autoimmune diseases

Stanford spinout Synthekine raises $107.5M on promise of new way to attack cancer, autoimmune diseases
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United States , Menlo Park , Stanford University , Rock Springs , San Francisco , Chris Garcia , Ron Leuty , Patrick Lupardus , Naiyer Rizvi , Debanjan Ray , Robin Knifsend , Laurene Powell Jobs , Rob Kastelein , Acterlion Pharmaceuticals , Portola Pharmaceuticals Inc , Merck Co , Genentech Inc , Columbia University Medical Center , Cytomx Therapeutics Inc , San Nektar Therapeutics Inc , Synthekine Inc , Abbvie Inc , Column Group , Bristol Myers Squibb Co , Staff Reporter , San Francisco Business Times ,

Synthekine Expands Board of Directors, Management Team and Scientific Advisory Board with New Key Appointments

Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Mardi Dier to its board of directors, Robin Knifsend as senior vice president of finance and operations and Antoni Ribas, M.D., Ph.D., to its scientific advisory board. ....

Antoni Ribas , Alexion Pharmaceuticals , Portola Pharmaceuticals , Robin Knifsend , Scientific Advisory Board , Ultragenyx Pharmaceutical , Senior Vice President , Stanford University , Janssen Pharmaceuticals , Synthekine Inc , Board Of Directors , அன்டோனி ரிபாஸ் ,